A non-bioabsorbable tubular device intended to be implanted in an obstructed biliary duct (e.g., common bile duct) to maintain luminal patency; it is not intended for vascular implantation. It may be a mesh structure or a continuous tube and is made entirely o
| Company | Devices | Share |
|---|---|---|
| Bard Peripheral Vascular, Inc. | 269 | 24% |
| Cordis Us Corp. | 213 | 19% |
| Covidien Lp | 163 | 15% |
| Cook Incorporated | 96 | 9% |
| M.I.Tech Co., Ltd. | 86 | 8% |
| Cook Ireland Ltd | 75 | 7% |
| Taewoongmedical.Co.,Ltd | 64 | 6% |
| Cordis Corporation | 49 | 4% |
| Boston Scientific Corporation | 48 | 4% |
| Ev3, Inc | 24 | 2% |
| Sewoon Medical Co., Ltd. | 12 | 1% |
| Medinol Ltd. | 8 | 1% |
Company = labeler of record on GUDID. 14 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| FGE | CATHETER, BILIARY, DIAGNOSTIC | 910 |
| NIO | STENT, ILIAC | 106 |
| FGE | Catheter, Biliary, Diagnostic | 102 |
| NIP | STENT, SUPERFICIAL FEMORAL ARTERY | 84 |
| FGE | Stents, drains and dilators for the biliary ducts | 83 |
| FGE | Stents, Drains And Dilators For The Biliary Ducts | 71 |
Use these as the dimensions to specify in a tender line.
1,114 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Bare-metal biliary stent", from 14 companies. The largest labeler is Bard Peripheral Vascular, Inc. with 24% of records.
FGE (CATHETER, BILIARY, DIAGNOSTIC), NIO (STENT, ILIAC), FGE (Catheter, Biliary, Diagnostic), NIP (STENT, SUPERFICIAL FEMORAL ARTERY)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add bare-metal biliary stent to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.